Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure.

Experimental and clinical psychopharmacology

Volumn 21, Issue 4, 2013, Pages 294-302

  Sanders, Nichole C ^a   Mancino, Michael J ^b   Gentry, W Brooks ^b   Guise, J Benjamin ^b   Bickel, Warren K ^b   Thostenson, Jeff ^b   Oliveto, Alison H ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMINE; AMINO ACID RECEPTOR BLOCKING AGENT; BUPRENORPHINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; GABAPENTIN; NARCOTIC ANTAGONIST;

ADULT; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIRECTLY OBSERVED THERAPY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INDUCTION CHEMOTHERAPY; MAINTENANCE CHEMOTHERAPY; MALE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATHOPHYSIOLOGY; PATIENT DROPOUTS; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SECONDARY PREVENTION; SEVERITY OF ILLNESS INDEX; SUBSTANCE WITHDRAWAL SYNDROME; URINE;

ADULT; AMINES; BUPRENORPHINE; CYCLOHEXANECARBOXYLIC ACIDS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIRECTLY OBSERVED THERAPY; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; INDUCTION CHEMOTHERAPY; MAINTENANCE CHEMOTHERAPY; MALE; NARCOTIC ANTAGONISTS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT DROPOUTS; PILOT PROJECTS; SECONDARY PREVENTION; SEVERITY OF ILLNESS INDEX; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84889568582     PISSN: None     EISSN: 19362293     Source Type: Journal    
DOI: 10.1037/a0033724     Document Type: Article

References (0)